Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Azafaros
Biotech
Former Seagen CEO takes on new role—Chutes & Ladders
Ex-Seagen leader Siegall to be MorphImmune CEO; Shanker beamed up to new CSO role; Inozyme's founding CEO to depart.
Max Bayer
,
Gabrielle Masson
Mar 24, 2023 9:30am
Novavax CEO to retire after 12 years—Chutes & Ladders
Jan 13, 2023 9:30am
European rare disease biotech Azafaros grabs $28M
Feb 6, 2020 9:03am